140 related articles for article (PubMed ID: 22992974)
1. ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.
Zadran S; Amighi A; Otiniano E; Wong K; Zadran H
Tumour Biol; 2012 Dec; 33(6):2411-21. PubMed ID: 22992974
[TBL] [Abstract][Full Text] [Related]
2. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.
Fang M; Shen Z; Huang S; Zhao L; Chen S; Mak TW; Wang X
Cell; 2010 Nov; 143(5):711-24. PubMed ID: 21074248
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.
Vogiatzi F; Brandt DT; Schneikert J; Fuchs J; Grikscheit K; Wanzel M; Pavlakis E; Charles JP; Timofeev O; Nist A; Mernberger M; Kantelhardt EJ; Siebolts U; Bartel F; Jacob R; Rath A; Moll R; Grosse R; Stiewe T
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8433-E8442. PubMed ID: 27956623
[TBL] [Abstract][Full Text] [Related]
4. ENTPD5, an endoplasmic reticulum UDPase, alleviates ER stress induced by protein overloading in AKT-activated cancer cells.
Shen Z; Huang S; Fang M; Wang X
Cold Spring Harb Symp Quant Biol; 2011; 76():217-23. PubMed ID: 22169232
[TBL] [Abstract][Full Text] [Related]
5. ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.
Xue Y; Wu L; Liu Y; Ma Y; Zhang L; Ma X; Yang Y; Chen J
PLoS One; 2015; 10(3):e0120046. PubMed ID: 25794010
[TBL] [Abstract][Full Text] [Related]
6. Identifying small molecule probes of ENTPD5 through high throughput screening.
Durst MA; Ratia K; Lavie A
PLoS One; 2019; 14(6):e0210305. PubMed ID: 31242188
[TBL] [Abstract][Full Text] [Related]
7. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
[No Abstract] [Full Text] [Related]
8. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
9. The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family.
MacCarthy CM; Notario V
Int J Oncol; 2013 Oct; 43(4):1244-52. PubMed ID: 23921441
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.
Kaur H; Burden-Gulley SM; Phillips-Mason PJ; Basilion JP; Sloan AE; Brady-Kalnay SM
Neuro Oncol; 2012 May; 14(5):561-73. PubMed ID: 22505657
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis.
Zhou J; Xu T; Qin R; Yan Y; Chen C; Chen Y; Yu H; Xia C; Lu Y; Ding X; Wang Y; Cai X; Chen J
J Neurooncol; 2012 Nov; 110(2):195-203. PubMed ID: 22972189
[TBL] [Abstract][Full Text] [Related]
12. MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Kuan CT; Wakiya K; Herndon JE; Lipp ES; Pegram CN; Riggins GJ; Rasheed A; Szafranski SE; McLendon RE; Wikstrand CJ; Bigner DD
BMC Cancer; 2010 Sep; 10():468. PubMed ID: 20809959
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.
Pike LS; Smift AL; Croteau NJ; Ferrick DA; Wu M
Biochim Biophys Acta; 2011 Jun; 1807(6):726-34. PubMed ID: 21692241
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells.
Gwak H; Kim S; Dhanasekaran DN; Song YS
Cancer Lett; 2016 Feb; 371(2):347-53. PubMed ID: 26704305
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia.
Hofstetter CP; Burkhardt JK; Shin BJ; Gürsel DB; Mubita L; Gorrepati R; Brennan C; Holland EC; Boockvar JA
PLoS One; 2012; 7(1):e30059. PubMed ID: 22253878
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest.
Read R; Hansen G; Kramer J; Finch R; Li L; Vogel P
Vet Pathol; 2009 May; 46(3):491-504. PubMed ID: 19176496
[TBL] [Abstract][Full Text] [Related]
17. The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas.
Cheng CP; Huang LC; Chang YL; Hsieh CH; Huang SM; Hueng DY
Oncotarget; 2016 Jul; 7(27):41460-41472. PubMed ID: 27166188
[TBL] [Abstract][Full Text] [Related]
18. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
[TBL] [Abstract][Full Text] [Related]
19. Invasive glioblastoma cells acquire stemness and increased Akt activation.
Molina JR; Hayashi Y; Stephens C; Georgescu MM
Neoplasia; 2010 Jun; 12(6):453-63. PubMed ID: 20563248
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]